News | Reading Time 3 minutes
An exclusive agreement that will bring direct benefits to probiotic consumers, worldwide
Lallemand Health Solutions and Aventus Innovations have signed a global agreement to grant Lallemand exclusive use of Aventus’ flagship technology, NutraJIT®, for probiotic applications. NutraJIT® is a patented, all-natural innovative oral delivery platform, offering a unique combination of gastric protection and controlled release particularly suitable with active ingredients like probiotics. It has already been convincingly tested and used to protect other ingredients, like melatonin, vitamins, and certain minerals.
“As a young innovative Canadian company which develops oral delivery technologies intended for use by dietary supplements companies like Lallemand Health Solutions, we are thrilled to have concluded this agreement which will allow our ingredients to serve consumers, worldwide” details Nicolas Kronström, Chief Operating Officer at Aventus Innovations.
“This protective technology is efficient on both capsules and tablets, which is a great addition to our existing portfolio. NutraJIT® is a versatile vehicle for active ingredients to make their way to their site of action, without being affected by the stomach fluids acidity and with reduced gastric side effects.” explains Marie-Eve Boyte, Scientific Affairs Director at Lallemand Health Solutions.
“NutraJIT® is a derivative of food-product protein and, as such, ticks all the boxes for consumers: all-natural, allergen-free, clean label and added protection. Even though we have existing protective technologies to make sure all our probiotic strains reach their site of action, NutraJIT® brings its own additional benefits for consumers. Basically, the ingredient creates a gel barrier in a low pH environment, protecting the probiotic formula from stomach acidity. When reaching the intestines, it will desegregate as the pH is increasing, releasing the bacteria where they need to be. We are eager to bring this new attractive solution to the probiotic market and are actively preparing the launch for the coming fall.” adds Bérengère Feuz, Marketing Director at Lallemand Health Solutions.
About Aventus Innovations and the NutraJIT® Oral Delivery Platform
Aventus Innovations is a privately held Canadian company that specializes in the creation, development and commercialization of innovative oral delivery technologies for use, by companies, in dietary supplements, nutraceuticals and pharmaceuticals products.
Aventus’s patented technology platform, NutraJIT® – which stands for nutraceuticals delivered just in time – provides businesses with the ability to add unique benefits, such as protection against stomach acids, the reduction of side effects, and time-release capabilities, to existing and future products. Initially developed for the probiotic market, this easy-to-use oral delivery platform has since extended its features to other products and can be used in combination with a wide range of active ingredients, such as vitamins, minerals, herbal extracts, and specialty supplements.
Aventus Innovations takes great pride in providing current and potential customers with best-in-class oral delivery solutions that meet their needs and high standards… now and well into the future.
About Lallemand Health Solutions
Lallemand Health Solution is a vertically integrated probiotic manufacturer specialized in the research, development and manufacturing of ready-to-market and custom probiotic formulations. Its products target specific populations and health segments including gut health, immune health, mental health, women’s health, skin health, oral health, sport and metabolism. Probiotics are produced in cutting-edge plants certified to the highest quality. More than 600 probiotic formulas are currently marketed in over 60 countries across five continents. Lallemand Health Solution is proud to have an open culture of entrepreneurial spirit and is pursuing a never-ending quest to look out for better ways to improve quality, productivity and to create innovative products.
̶̶̶ 30 ̶̶
MEDIA CONTACT
Marilou Luneau, Content Manager, Lallemand Health Solutions, mluneau@lallemand.com
Nicolas Kronström, COO, Aventus Innovations, nk@aventusinnov.com
Published Jun 13, 2021 | Updated Jan 11, 2024
Related articles
Need specific information?
Talk to an expert